Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06547892

Use of Vasopressin in Patients at High Risk of Acute Kidney Injury Admitted to the ICU

Led by Hospital do Coracao · Updated on 2025-04-13

60

Participants Needed

1

Research Sites

34 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Renal dysfunction is a frequent complication in patients admitted to intensive care units (ICUs), associated with high morbidity and mortality. Current therapeutic options to prevent this condition are limited and lack robust scientific evidence. This pilot study consists of a multicenter, blinded, randomized clinical trial, unprecedented in the literature to date, aiming to fill this knowledge gap and offer new therapeutic perspectives to improve renal outcomes in critically ill patients admitted to the ICU.

CONDITIONS

Official Title

Use of Vasopressin in Patients at High Risk of Acute Kidney Injury Admitted to the ICU

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients (18 years or older)
  • Admitted to intensive care units
  • Predicted risk of acute kidney injury score of 5 or higher based on clinical and laboratory data at ICU admission
Not Eligible

You will not qualify if you...

  • More than 24 hours since admission to the ICU
  • Current use of vasopressors at study entry
  • Mean arterial pressure greater than 90 mmHg
  • Hyponatremia (sodium less than 130 mmol/L)
  • Severe traumatic brain injury with Glasgow Coma Scale less than 8
  • Undergoing elective surgeries
  • Chronic kidney disease on dialysis or acute kidney injury requiring or expected to require renal replacement therapy within 24 hours
  • Suspected or confirmed acute mesenteric ischemia
  • Expected death within 24 hours
  • Medical team not committed to full treatment at inclusion
  • Prior participation in this study
  • Pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Matheus Liguori Feliciano da Silva

São Paulo, São Paulo, Brazil, 03115-001

Actively Recruiting

Loading map...

Research Team

M

Matheus Silva

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here